Sort
16,179 grants matching “malaria”
Structural Studies of Togaviruses
$646,229Richard J. Kuhn · Purdue University · R01 · FY2021 · AI
Structural Studies of Togaviruses
$646,229Richard J. Kuhn · Purdue University · R01 · FY2023 · AI
Structural Studies of Togaviruses
$646,229Richard J. Kuhn · Purdue University · R01 · FY2020 · AI
Molecular Analysis of Plasmodium vivax Surface Antigens
$645,851Emory University · R01 · FY2004 · AI
Multi-scale model of microbial phenotype modulation by mucins
$645,815Jason Papin · University Of Virginia · R01 · FY2020 · AI
The molecular and cellular basis of short-range host cue sensing in mosquito vectors
$645,648Paul A Garrity · Brandeis University · R01 · FY2024 · AI
Human mobility models to forecast disease dynamics and the effectiveness of public health interventions
$645,548Amy Wesolowski · Johns Hopkins University · R01 · FY2022 · AI
Perturbations of host cell signaling by a complex hepatotropic pathogen
$645,448Alexis Kaushansky · Seattle Children'S Hospital · R01 · FY2024 · AI
Health Professionals Education Partnership Initiative Ethiopia
$645,432Miliard Derbew · Addis Ababa University · R25 · FY2020 · TW
Human mobility models to forecast disease dynamics and the effectiveness of public health interventions
$645,377Amy Wesolowski · Johns Hopkins University · R01 · FY2023 · AI
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma
$645,327Rosemary Rochford · University Of Colorado Denver · R01 · FY2021 · AI
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma
$645,327Gabriela M Samayoa Reyes · University Of Colorado Denver · R01 · FY2024 · AI
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma
$645,327Katherine R Sabourin · University Of Colorado Denver · R01 · FY2023 · AI
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma
$645,327Rosemary Rochford · University Of Colorado Denver · R01 · FY2022 · AI
Community I-STAR Mozambique: Community Implementation of SBIRT using Technology for Alcohol use Reduction in Mozambique
$645,256Milton L Wainberg · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2019 · AA
Novel Therapeutics to Target Parasite Cytochrome bc1
$644,982Michael Kevin Riscoe · Oregon Health & Science University · R01 · FY2022 · AI
Plasmodium vivax Erythrocyte Invasion Mechanisms and Humoral Immune Response in Duffy Negative Africans
$644,879Eugenia Lo · Drexel University · R01 · FY2025 · AI
Community I-STAR Mozambique: Community Implementation of SBIRT using Technology for Alcohol use Reduction in Mozambique
$644,782Milton L Wainberg · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2021 · AA
Designed Antimalarial Agents Overcoming Chloroquine-Resistance
$644,773David H Peyton · Designmedix, Inc. · R42 · FY2010 · AI
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance
$644,309Gretchen Lano Birbeck · University Of Rochester · R01 · FY2019 · NS
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure
$644,275David Serre · University Of Maryland Baltimore · R01 · FY2022 · AI
Effector and regulatory T cell responses and protection from clinical malaria
$644,253Margaret E Feeney · University Of California, San Francisco · R01 · FY2011 · AI
Malaria Parasite Receptors And Host Cell Ligands
$644,237Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Malaria associated pathogenesis of chronic kidney disease (MAP-CKD)
$644,039Andrea L. Conroy · Indiana University Indianapolis · R01 · FY2022 · AI
Proline homeostasis: a novel mediator of drug tolerance in Plasmodium falciparum
$643,981Ralph Mazitschek · Harvard School Of Public Health · R01 · FY2021 · AI